- Home
- PRPO vs EVOK Comparison
PRPO vs EVOK Comparison
Compare PRPO & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- EVOK
- Stock Information
- Founded
- PRPO N/A
- EVOK 2007
- Country
- PRPO United States
- EVOK United States
- Employees
- PRPO N/A
- EVOK N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- PRPO Industrials
- EVOK Health Care
- Exchange
- PRPO Nasdaq
- EVOK Nasdaq
- Market Cap
- PRPO N/A
- EVOK 4.2M
- IPO Year
- PRPO N/A
- EVOK 2013
- Fundamental
- Price
- PRPO $11.79
- EVOK $2.70
- Analyst Decision
- PRPO
- EVOK
- Analyst Count
- PRPO 0
- EVOK 0
- Target Price
- PRPO N/A
- EVOK N/A
- AVG Volume (30 Days)
- PRPO 9.8K
- EVOK 19.3K
- Earning Date
- PRPO 08-12-2025
- EVOK 08-12-2025
- Dividend Yield
- PRPO N/A
- EVOK N/A
- EPS Growth
- PRPO N/A
- EVOK N/A
- EPS
- PRPO N/A
- EVOK N/A
- Revenue
- PRPO $20,029,000.00
- EVOK $11,594,083.00
- Revenue This Year
- PRPO N/A
- EVOK $57.82
- Revenue Next Year
- PRPO N/A
- EVOK $59.12
- P/E Ratio
- PRPO N/A
- EVOK N/A
- Revenue Growth
- PRPO 26.67
- EVOK 89.89
- 52 Week Low
- PRPO $3.90
- EVOK $1.94
- 52 Week High
- PRPO $12.45
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- PRPO 65.45
- EVOK 43.42
- Support Level
- PRPO $10.60
- EVOK $2.50
- Resistance Level
- PRPO $11.70
- EVOK $2.84
- Average True Range (ATR)
- PRPO 0.60
- EVOK 0.20
- MACD
- PRPO -0.08
- EVOK -0.01
- Stochastic Oscillator
- PRPO 79.57
- EVOK 47.45
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.